A RANDOMIZED PHASE 2/3, DOUBLE-BLIND, PLACEBO-CONTROLLED ADAPTIVE STUDY EVALUATING THE EFFICACY AND SAFETY OF MOMELOTINIB IN PARTICIPANTS WITH VEXAS SYNDROME

Registry ID

223401

Source registry

HEALTH_CANADA

Status

Pending

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

GLAXOSMITHKLINE INC

Last update

2026-06-09

Conditions

• VEXAS SYNDROME

Related clinical trials

• PAXIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE-FINDING PHASE 2 STUDY (PART 1) FOLLOWED BY AN OPEN-LABEL PERIOD (PART 2) TO ASSESS THE EFFICACY AND SAFETY OF PACRITINIB IN PATIENTS WITH VEXAS SYNDROME

View on source registry